| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.39 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.64 | 0.01 |